Bioorthogonal chemistry-driven multi-enzyme strategy for efficient terpenoid biosynthesis
Bioresource Technology · 2026-11 · 459 · 135232
DOI: 10.1016/j.biortech.2026.135232 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioresource Technology, 2026-11. Verfasst von Chaoyue Nie und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Materials, Chemistry and Chemical Engineering, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China. Hauptthemen laut MEDLINE: Terpenes, Multienzyme Complexes. Die Arbeit nennt 49 Literaturangaben. Gefördert von: Zhejiang Province Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Conventional in vivo terpenoid biosynthesis is often limited by the complexity of the intracellular environment and inefficient pathway flux. To overcome these challenges, an in vitro multi-enzyme cascade strategy was developed for the synthesis of high-value terpenoids. Using bioorthogonal protein pairing, six enzymes from the shortened mevalonate (MVA) pathway were assembled into ordered cross-linked enzyme complexes (O-CLEs), enabling controlled spatial organization. Multi-layer fluorescence labeling technology (MLFLT) confirmed the ordered arrangement of enzymes within the O-CLEs. For β-farnesene production, the assembled O-CLEs yielded 49.08 ± 1.91 mg/L of product, representing a 1.39-fold increase compared with the WT free-enzyme mixture (35.33 ± 0.51 mg/L) and a 3.03-fold increase compared with the (randomly cross-linked enzyme complexes) R-CLEs system 16.21 ± 1.68 mg/L), while retaining 62 ± 9% of initial activity after six successive reuse cycles. Notably, replacing β-farnesene synthase (FS) with taxadiene synthase (TXS) readily extended the strategy to taxadiene biosynthesis, demonstrating the modular design and general applicability of this approach. Thus, this bioorthogonal chemistry-driven, ordered multi-enzyme immobilization strategy offers a robust, generalizable, and reusable platform for the sustainable in vitro production of high-value terpenoids, advancing the development of in vitro synthetic biology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Materials, Chemistry and Chemical Engineering, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China.
- School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China.
- School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China. Electronic address: xyye@hznu.edu.cn.
- College of Materials, Chemistry and Chemical Engineering, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China. Electronic address: waming@hznu.edu.cn.
Förderung
- Zhejiang Province Natural Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Nie, C., Li, M., Chen, X., Jiang, J., Pan, J., Zuo, X., Jiang, N., Du, L., Ye, X. Y., & Wang, A. (2026). Bioorthogonal chemistry-driven multi-enzyme strategy for efficient terpenoid biosynthesis. Bioresource Technology, 459, 135232. https://doi.org/10.1016/j.biortech.2026.135232
Vancouver
Nie C, Li M, Chen X, Jiang J, Pan J, Zuo X, et al. Bioorthogonal chemistry-driven multi-enzyme strategy for efficient terpenoid biosynthesis. Bioresource Technology. 2026;459:135232. doi:10.1016/j.biortech.2026.135232
BibTeX
@article{Nie2026,
author = {Nie, Chaoyue and Li, Mijun and Chen, Xinxin and Jiang, Jing and Pan, Jiayi and Zuo, Xiangxiang and Jiang, Nannan and Du, Linmeng and Ye, Xiang-Yang and Wang, Anming},
title = {Bioorthogonal chemistry-driven multi-enzyme strategy for efficient terpenoid biosynthesis},
journal = {Bioresource Technology},
year = {2026},
volume = {459},
pages = {135232},
doi = {10.1016/j.biortech.2026.135232}
}
EUVIMED